» Articles » PMID: 29030825

Analysis of LncRNA-Protein Interactions by RNA-Protein Pull-Down Assays and RNA Immunoprecipitation (RIP)

Overview
Specialty Molecular Biology
Date 2017 Oct 15
PMID 29030825
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) have important roles in shaping chromatin by targeting chromatin-modifying enzymes to distinct genomic sites. This section covers two methods to analyze lncRNA-protein interactions. The RNA-protein pull-down assays use either bead-bound proteins to capture in vitro transcripts, or immobilized synthetic RNAs to bind proteins from cell lysates. In the RNA immunoprecipitation (RIP) assay, endogenous RNAs are co-immunoprecipitated with a protein of interest. Both the methods can be applied to material from proliferating and quiescent cells, thus providing insights into how lncRNA-protein interactions are altered between these two cellular states.

Citing Articles

RNA-binding protein Trx regulates alternative splicing and promotes metastasis of HCC via interacting with LINC00152.

Teng X, Shang J, Du L, Huang W, Wang Y, Liu M J Gastroenterol Hepatol. 2024; 39(12):2892-2902.

PMID: 39343436 PMC: 11660213. DOI: 10.1111/jgh.16735.


Downregulation of Lnc-ABCA12-3 modulates UBQLN1 expression and protein homeostasis pathways in amyotrophic lateral sclerosis.

Yu Y, Pang D, Huang J, Li C, Cui Y, Shang H Sci Rep. 2024; 14(1):21383.

PMID: 39271939 PMC: 11399266. DOI: 10.1038/s41598-024-72666-8.


Role of long noncoding RNAs in diabetes-associated peripheral arterial disease.

Tapia A, Liu X, Malhi N, Yuan D, Chen M, Southerland K Cardiovasc Diabetol. 2024; 23(1):274.

PMID: 39049097 PMC: 11271017. DOI: 10.1186/s12933-024-02327-7.


Transcription factor STAT4 counteracts radiotherapy resistance in breast carcinoma cells by activating the MALAT1/miR-21-5p/THRB regulatory network.

Guo L, Ding G, Ba Y, Tan B, Tian L, Wang K Am J Cancer Res. 2024; 14(4):1501-1522.

PMID: 38726265 PMC: 11076251. DOI: 10.62347/VSJU7227.


MiR-4492, a New Potential MicroRNA for Cancer Diagnosis and Treatment: A Mini Review.

Alizamir A, Amini M, Karbasi A, Beyrami M Chonnam Med J. 2024; 60(1):21-26.

PMID: 38304137 PMC: 10828084. DOI: 10.4068/cmj.2024.60.1.21.